TTK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.248000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.643000E-01
Normal-vs-Stage2
2.931000E-01
Normal-vs-Stage3
6.612200E-01
Normal-vs-Stage4
3.357200E-01
Stage1-vs-Stage2
4.370000E-01
Stage1-vs-Stage3
7.944200E-01
Stage1-vs-Stage4
5.658000E-01
Stage2-vs-Stage3
3.495200E-01
Stage2-vs-Stage4
8.871800E-01
Stage3-vs-Stage4
3.590400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.386800E-01
Normal-vs-AfricanAmerican
3.315000E-01
Normal-vs-Asian
2.084600E-01
Caucasian-vs-AfricanAmerican
6.008000E-01
Caucasian-vs-Asian
8.015800E-01
AfricanAmerican-vs-Asian
4.181400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.053200E-01
Normal-vs-Female
3.292000E-01
Male-vs-Female
2.442000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.565400E-01
Normal-vs-Age(41-60Yrs)
3.606600E-01
Normal-vs-Age(61-80Yrs)
2.784400E-01
Normal-vs-Age(81-100Yrs)
2.283600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.807800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.738200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.766380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.835000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.350000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.398000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.943400E-01
Normal-vs-Daily Drinker
3.747600E-01
Normal-vs-Weekly Drinker
4.505400E-01
Normal-vs-Occasional Drinker
2.130200E-01
Normal-vs-Social Drinker
2.272800E-01
Non Drinker-vs-Daily Drinker
7.016200E-01
Non Drinker-vs-Weekly Drinker
5.238400E-01
Non Drinker-vs-Occasional Drinker
5.687600E-01
Non Drinker-vs-Social Drinker
8.443200E-01
Daily Drinker-vs-Weekly Drinker
4.084200E-01
Daily Drinker-vs-Occasional Drinker
3.157600E-01
Daily Drinker-vs-Social Drinker
5.400200E-01
Weekly Drinker-vs-Occasional Drinker
7.408600E-01
Weekly Drinker-vs-Social Drinker
5.971000E-01
Occasional Drinker-vs-Social Drinker
7.131600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.507600E-01
Normal-vs-Grade 2
5.913200E-01
Normal-vs-Grade 3
6.247600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.904000E-03
Grade 1-vs-Grade 3
2.827500E-04
Grade 1-vs-Grade 4
5.507600E-01
Grade 2-vs-Grade 3
7.753900E-02
Grade 2-vs-Grade 4
5.913200E-01
Grade 3-vs-Grade 4
6.247600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.766000E-01
Normal-vs-NonDiabetic
3.178400E-01
Diabetic-vs-NonDiabetic
2.473600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.162980E-01
Normal-vs-NoPancreatitis
3.737000E-01
Pancreatitis-vs-NoPancreatitis
6.482000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.750000E-01
Normal-vs-N1
3.140400E-01
N0-vs-N1
3.853600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.949700E-02
Normal-vs-TP53-NonMutant
3.356400E-01
TP53-Mutant-vs-TP53-NonMutant
1.69810999999243E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
